Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sina Haftchenary

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Anti-Cancer Drugs|November 11, 2010
Inhibiting aberrant Stat3 function with molecular therapeutics: a progress reportSina Haftchenary, Miriam Avadisian, Patrick T Gunning
Molecular and Cellular Biochemistry|April 22, 2015
Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cellsKatja Linher-Melville, Sina Haftchenary, Patrick Gunning, et al.
The Journal of Biological Chemistry|October 8, 2014
Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerizationDiana Resetca, Sina Haftchenary, Patrick T Gunning, et al.
Biophysical Chemistry|June 9, 2009
Binding interactions in early- and late-stage amyloid aggregates of TTR(105-115)Yanfang Liang, Shohreh Zahedi Jasbi, Sina Haftchenary, et al.
Plos One|August 12, 2016
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- ActivityKatja Linher-Melville, Mina G Nashed, Robert G Ungard, et al.
ACS Medicinal Chemistry Letters|January 19, 2011
Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR StudiesVijay M Shahani, Peibin Yue, Sina Haftchenary, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Retraction of "Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies"Vijay M Shahani, Peibin Yue, Sina Haftchenary, et al.
Bioorganic & Medicinal Chemistry|July 2, 2013
A 2,6,9-hetero-trisubstituted purine inhibitor exhibits potent biological effects against multiple myeloma cellsVijay M Shahani, Daniel P Ball, Allan V Ramos, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Identification of Bidentate Salicylic Acid Inhibitors of PTP1BSina Haftchenary, Andriana O Jouk, Isabelle Aubry, et al.
Therapeutic Advances in Medical Oncology|March 2, 2023
Quality of life with ribociclib <i>versus</i> abemaciclib as first-line treatment of HR+/HER2- advanced breast cancer: a matching-adjusted indirect comparisonHope S Rugo, Victoria Harmer, Joyce O'Shaughnessy, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|November 11, 2010
Inhibiting aberrant Stat3 function with molecular therapeutics: a progress reportSina Haftchenary, Miriam Avadisian, Patrick T Gunning
Molecular and Cellular Biochemistry|April 22, 2015
Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cellsKatja Linher-Melville, Sina Haftchenary, Patrick Gunning, et al.
The Journal of Biological Chemistry|October 8, 2014
Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerizationDiana Resetca, Sina Haftchenary, Patrick T Gunning, et al.
Biophysical Chemistry|June 9, 2009
Binding interactions in early- and late-stage amyloid aggregates of TTR(105-115)Yanfang Liang, Shohreh Zahedi Jasbi, Sina Haftchenary, et al.
Plos One|August 12, 2016
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- ActivityKatja Linher-Melville, Mina G Nashed, Robert G Ungard, et al.
ACS Medicinal Chemistry Letters|January 19, 2011
Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR StudiesVijay M Shahani, Peibin Yue, Sina Haftchenary, et al.
ACS Medicinal Chemistry Letters|October 18, 2023
Retraction of "Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies"Vijay M Shahani, Peibin Yue, Sina Haftchenary, et al.
Bioorganic & Medicinal Chemistry|July 2, 2013
A 2,6,9-hetero-trisubstituted purine inhibitor exhibits potent biological effects against multiple myeloma cellsVijay M Shahani, Daniel P Ball, Allan V Ramos, et al.
ACS Medicinal Chemistry Letters|September 24, 2015
Identification of Bidentate Salicylic Acid Inhibitors of PTP1BSina Haftchenary, Andriana O Jouk, Isabelle Aubry, et al.
Therapeutic Advances in Medical Oncology|March 2, 2023
Quality of life with ribociclib <i>versus</i> abemaciclib as first-line treatment of HR+/HER2- advanced breast cancer: a matching-adjusted indirect comparisonHope S Rugo, Victoria Harmer, Joyce O'Shaughnessy, et al.
Pageof 2